How To Speculate On This Biotech Stock With “A Historically Bullish Signal Flashing”
The biotech stock highlighted in today’s article is already up 173% so far this year, and now the author advises that “a historically bullish signal…
This Biotech Stock Has High Return Potential – And A Potential Bump In The Road
The biotech company highlighted in today’s article, specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, is one that…
Biggest Biotech Bargains
“Although the vast majority of biotech stocks are losing money, a handful of these profitable drug developers are valued at levels that make them absolute…
The Best Play For Biotech’s Breakout May Not Be The Obvious Play
“Biotech stocks are breaking out,” declares the author of today’s article. When it comes to playing this breakout, however, he advises that the obvious play…
Why These 2 Overlooked Biotech Stocks Are Deserving Of Attention
“Both of these biotechs deserve a lot more attention than they’ve been receiving,” asserts the author of today’s article in regards to two clinical-stage biotech…
PDUFA Dates: “Make-Or-Break Catalysts” For Biotech Stocks In October
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Product Candidates For Wet Underarms And Dry Eyes Have These 2 Stocks Dripping With Upside Potential
Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted…
A Quick Look At Short Interest In The Top Biotech Stocks
What does the most recent data indicate about short interest in the top biotech stocks? The short answer, today’s article notes, is that “short interest…
Biotech Penny Stocks To Buy (Or Bypass)
“Call it what you will, but I think traders who’ve dug into the biotech space initially came for the COVID, then figured out there’s far…
This Preclinical Biotech Is Going Clinical This Year – And Goldman Says It’s A Buy
Today’s article highlights a biotech firm that, after being relatively quiet for several years, the market may begin to take notice of as it goes…